RGNX
Regenxbio Inc
NASDAQ: RGNX · HEALTHCARE · BIOTECHNOLOGY
$8.97
+6.79% today
Updated 2026-04-30
Market cap
$452.17M
P/E ratio
—
P/S ratio
2.65x
EPS (TTM)
$-3.76
Dividend yield
—
52W range
$7 – $16
Volume
0.8M
Regenxbio Inc (RGNX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-48.8%
Last 4 quarters
Revenue YoY growth
+43.0%
Most recent quarter
EPS YoY growth
-28.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.4%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-5.4%
2026-03-05
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-05 | $-1.30 | -80.7% | $9.14 | $8.65 | -5.4% |
| 2025-11-06 | $-1.20 | +7.7% | $11.61 | $11.21 | -3.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.72 | $-1.30 | -80.7% | $30.34M | +43.0% |
| 2025-09-30 | $-1.30 | $-1.20 | +7.7% | $29.73M | +22.9% |
| 2025-06-30 | $-0.94 | $-1.38 | -46.8% | $21.36M | -4.2% |
| 2025-03-31 | $0.49 | $0.12 | -75.3% | $89.01M | +469.8% |
| 2024-12-31 | $-1.08 | $-1.01 | +6.9% | $21.21M | -4.5% |
| 2024-09-30 | $-1.12 | $-1.17 | -4.5% | $24.20M | -16.3% |
| 2024-06-30 | $-1.29 | $-1.05 | +18.6% | $22.30M | +11.6% |
| 2024-03-31 | $-1.26 | $-1.33 | -5.6% | $15.62M | -18.4% |
| 2023-12-31 | $-1.27 | $-1.43 | -12.6% | $22.21M | — |
| 2023-09-30 | $-1.52 | $-1.41 | +7.2% | $28.91M | — |
| 2023-06-30 | $-1.38 | $-1.66 | -20.3% | $19.98M | — |
| 2023-03-31 | $-1.54 | $-1.53 | +0.6% | $19.14M | — |
Frequently asked questions
Has Regenxbio Inc beaten earnings estimates?
Regenxbio Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -48.8% over the last 4 quarters.
How does RGNX stock react to earnings?
RGNX stock has moved an average of -4.4% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Regenxbio Inc's revenue growth rate?
Regenxbio Inc reported year-over-year revenue growth of +43.0% in its most recent quarter, with EPS growing -28.7% year-over-year.